Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Statistics

Total Valuation

ETR:HPHA has a market cap or net worth of EUR 125.83 million. The enterprise value is 96.58 million.

Market Cap	125.83M
Enterprise Value	96.58M

Important Dates

The next estimated earnings date is Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

ETR:HPHA has 46.60 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	n/a
Shares Outstanding	46.60M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+8.17%
Owned by Insiders (%)	2.37%
Owned by Institutions (%)	1.17%
Float	9.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.37
PB Ratio	4.08
P/TBV Ratio	5.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.98
EV / Sales	14.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.21

Financial Position

The company has a current ratio of 5.95, with a Debt / Equity ratio of 0.01.

Current Ratio	5.95
Quick Ratio	4.42
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-154.82

Financial Efficiency

Return on equity (ROE) is -48.33% and return on invested capital (ROIC) is -31.65%.

Return on Equity (ROE)	-48.33%
Return on Assets (ROA)	-20.82%
Return on Invested Capital (ROIC)	-31.65%
Return on Capital Employed (ROCE)	-41.40%
Revenue Per Employee	65,231
Profits Per Employee	-184,590
Employee Count	105
Asset Turnover	0.10
Inventory Turnover	0.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.42% in the last 52 weeks. The beta is 1.46, so ETR:HPHA's price volatility has been higher than the market average.

Beta (5Y)	1.46
52-Week Price Change	-9.42%
50-Day Moving Average	2.61
200-Day Moving Average	2.50
Relative Strength Index (RSI)	58.95
Average Volume (20 Days)	5,111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:HPHA had revenue of EUR 6.85 million and -19.38 million in losses. Loss per share was -0.42.

Revenue	6.85M
Gross Profit	5.07M
Operating Income	-21.83M
Pretax Income	-19.38M
Net Income	-19.38M
EBITDA	-21.10M
EBIT	-21.83M
Loss Per Share	-0.42

Balance Sheet

The company has 29.42 million in cash and 164,030 in debt, giving a net cash position of 29.26 million or 0.63 per share.

Cash & Cash Equivalents	29.42M
Total Debt	164,030
Net Cash	29.26M
Net Cash Per Share	0.63
Equity (Book Value)	30.87M
Book Value Per Share	0.66
Working Capital	39.57M

Cash Flow

In the last 12 months, operating cash flow was -29.59 million and capital expenditures -456,020, giving a free cash flow of -30.04 million.

Operating Cash Flow	-29.59M
Capital Expenditures	-456,020
Free Cash Flow	-30.04M
FCF Per Share	-0.64

Margins

Gross margin is 74.01%, with operating and profit margins of -318.71% and -282.98%.

Gross Margin	74.01%
Operating Margin	-318.71%
Pretax Margin	-282.98%
Profit Margin	-282.98%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ETR:HPHA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	-15.40%
FCF Yield	-23.88%

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

ETR:HPHA has an Altman Z-Score of -5.26. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.26
Piotroski F-Score	n/a